A mother is left devastated and demanding answers when her son, who was only 20 years old, died 12 hours after receiving the Pfizer vaccine.
The mother, Tricia Garrett, said her son Luke Garrett suffered a fatal seizure brought on by a sudden spike in his temperature. Mr. Garrett suffered from muscular dystrophy and was very afraid of contracting the virus so he was very excited for the opportunity to receive the vaccine so he could ‘live his life’.
Mother-of-two Mrs Garrett said: ‘I didn’t want him to get it. Luke had been shielding for about a year.
‘He used to have support workers who came in three times a week, he also had high-functioning autism and needed support for that but he cancelled it all because he was that scared of Covid.
‘He was excited about going to get his Covid jab and being able to get back out into the world and live his life.
‘It wasn’t even 12 hours after his Covid jab that he died.
‘His whole body was in horrendous pain, he had a really high temperature; normally with his condition, his legs can end up in pain but this was different.
‘Before he died, the arm he got the injection in was really painful.
‘He then suffered a seizure, which has never happened before.
‘He started to fit and there was foam coming out of his mouth.’
When speaking about the health of her son Mrs Garrett said, ‘Our son was fit and well, doctors used to say he was one of the better patients they had seen.
The Medicines and Healthcare products Regulatory Agency (MHRA) are investigating Mr Garrett’s death.
Click here to read more.
CDC and FDA Urge Pause on J&J Vaccine After “Rare and Severe” Blood Clots Occurred
The Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) have issued a joint statement urging states to “pause” the use of the Johnson and Johnson COVID-19 vaccine after those who received it experienced severe blood clotting.
The statement reads, in part:
CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine. In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia). All six cases occurred among women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination.
The statement called the side effect “extremely rare” and said the CDC would convene a meeting of the Advisory Committee on Immunization Practices (ACIP) tomorrow to review the cases further. The FDA will review the CDC’s analysis and also plans to investigate the cases. “Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution,” reads the statement.
In the past week, administration of the Johnson and Johnson vaccine was halted at four different locations in Georgia, Colorado, Iowa and North Carolina after numerous adverse reactions, such as fainting and lightheadedness, occurred.
Death Possibly Connected To Johnson & Johnson Vaccine Being Investigated By CDC
Negative reactions are accumulating across the country to the Covid vaccine and now a woman’s death is being investigated by the CDC after she received the single-dose of the the Johnson & Johnson vaccine.
A statement from Virginia State Vaccination Coordinator Danny Avula confirmed that the Centers for Disease Control and Prevention is investigating the death which occurred in March for its potential link to the vaccine.
The Virginia death was reported to the CDC’s Vaccine Adverse Event Reporting System, Avula said.
Johnson & Johnson said on Tuesday that it would pause its clinical trials and delay the rollout of its shot in Europe until the probe in the U.S. was ironed out.
Federal health agencies on Tuesday called for a pause on administering the Johnson & Johnson vaccine to dig deeper into reports from six women between the ages of 18 and 48 who said they fell ill with a “a rare and severe type of blood clot” – as described by the CDC – within two weeks of receiving the vaccine. Only one woman has died so far.
Nearly 7 million doses of the vaccine have been administered in the U.S.
The CDC is set to convene a meeting on Wednesday to review the cases.
The pause is expected to be lifted in the near-future.
Johnson & Johnson assured in a statement that the health and safety of people who use its products is its number one priority.